Literature DB >> 14759612

Progestogen-only pills and high blood pressure: is there an association? A literature review.

Sabina F Hussain1.   

Abstract

The progestogen-only pill (POP) is a contraceptive option for women who have high blood pressure either induced by use of combined oral pills or due to other causes; as long as it is well controlled and monitored. Combined oral contraception (COC) and Depo-Provera have been implicated in increased cardiovascular risk following use. High blood pressure has been theorized to be the critical path that leads to this increased risk. POP is the recommended method for women who are at risk of coronary heart disease due to presence of risk factors like hypertension. In order to offer POP as a safe, alternative contraception to women who develop hypertension on COCs or those who are at increased cardiovascular risk, it is important to take into account evidence of no association of high blood pressure with POP use. A search of published medical literature (PUBMED and Cochrane database) was undertaken with this objective. A total of four articles were selected for final review after application of inclusion and exclusion criteria. Three of these were prospective control trials and one a cross-sectional survey. There was no randomized study to answer this question. The results of these studies consistently reported no significant association of high blood pressure with use of POPs for up to 2-3 years of follow-up.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14759612     DOI: 10.1016/j.contraception.2003.09.002

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  8 in total

1.  Types of oral contraceptives and breast cancer survival among women enrolled in Medicaid: A competing-risk model.

Authors:  Marsha E Samson; Swann Arp Adams; Caroline M Mulatya; Jiajia Zhang; Charles L Bennett; James Hebert; Susan E Steck
Journal:  Maturitas       Date:  2016-10-22       Impact factor: 4.342

2.  Chronic estradiol-17β exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol.

Authors:  Madhan Subramanian; Priya Balasubramanian; Hannah Garver; Carrie Northcott; Huawei Zhao; Joseph R Haywood; Gregory D Fink; Sheba M J MohanKumar; P S MohanKumar
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-03-16       Impact factor: 3.619

Review 3.  Estrogen and hypertension.

Authors:  Muhammad S Ashraf; Wanpen Vongpatanasin
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

Review 4.  Contraceptive Strategies in Women With Heart Failure or With Cardiac Transplantation.

Authors:  Anjli Maroo; Johnny Chahine
Journal:  Curr Heart Fail Rep       Date:  2018-06

5.  Oral Contraceptive Use, Muscle Sympathetic Nerve Activity, and Systemic Hemodynamics in Young Women.

Authors:  Ronee E Harvey; Emma C Hart; Nisha Charkoudian; Timothy B Curry; Jason R Carter; Qi Fu; Christopher T Minson; Michael J Joyner; Jill N Barnes
Journal:  Hypertension       Date:  2015-06-22       Impact factor: 10.190

Review 6.  Secondary hypertension: interfering substances.

Authors:  Ehud Grossman; Franz H Messerli
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-07       Impact factor: 3.738

Review 7.  Hypertension in Women Across the Lifespan.

Authors:  Lama Ghazi; Natalie A Bello
Journal:  Curr Atheroscler Rep       Date:  2021-06-19       Impact factor: 5.967

8.  Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis.

Authors:  Marija Glisic; Sara Shahzad; Stergiani Tsoli; Mahmuda Chadni; Eralda Asllanaj; Lyda Z Rojas; Elizabeth Brown; Rajiv Chowdhury; Taulant Muka; Oscar H Franco
Journal:  Eur J Prev Cardiol       Date:  2018-05-10       Impact factor: 7.804

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.